As of early August 2026, the CDC has confirmed 2,465 measles cases nationwide, already surpassing the 2,289 recorded for all of 2025 and marking the highest annual total since 1991. Sustained transmission stems primarily from 38 active outbreaks—94% of cases are outbreak-associated—with the majority occurring among unvaccinated or under-vaccinated individuals in communities below the 95% herd-immunity threshold. Imported cases remain limited at 16, while local spread continues across 47 jurisdictions. A CDC advisory committee is reviewing elimination status this month for forwarding to PAHO, with weekly case updates and ongoing surveillance data releases likely to influence trader assessments of year-end totals through December.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertMasernfälle in den USA im Jahr 2026?
Masernfälle in den USA im Jahr 2026?
$7,829,288 Vol.
$7,829,288 Vol.
31. Dez. 2026
↑4,5k
51%
↑3k
95%
↑3,5 Tsd.
93%
↑4k
67%
↑5k
20%
↑7,5k
12%
↑10k
5%
↑12,5k
5%
$7,829,288 Vol.
$7,829,288 Vol.
31. Dez. 2026
↑4,5k
$20 Vol.
51%
↑3k
$89,695 Vol.
95%
↑3,5 Tsd.
$13,530 Vol.
93%
↑4k
$220,220 Vol.
67%
↑5k
$229,607 Vol.
20%
↑7,5k
$185,009 Vol.
12%
↑10k
$6,515,524 Vol.
5%
↑12,5k
$349,917 Vol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early August 2026, the CDC has confirmed 2,465 measles cases nationwide, already surpassing the 2,289 recorded for all of 2025 and marking the highest annual total since 1991. Sustained transmission stems primarily from 38 active outbreaks—94% of cases are outbreak-associated—with the majority occurring among unvaccinated or under-vaccinated individuals in communities below the 95% herd-immunity threshold. Imported cases remain limited at 16, while local spread continues across 47 jurisdictions. A CDC advisory committee is reviewing elimination status this month for forwarding to PAHO, with weekly case updates and ongoing surveillance data releases likely to influence trader assessments of year-end totals through December.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Markt eröffnet: Feb 16, 2026, 11:51 AM ET
Volumen
$7,829,288Enddatum
31. Dez. 2026Markt eröffnet
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early August 2026, the CDC has confirmed 2,465 measles cases nationwide, already surpassing the 2,289 recorded for all of 2025 and marking the highest annual total since 1991. Sustained transmission stems primarily from 38 active outbreaks—94% of cases are outbreak-associated—with the majority occurring among unvaccinated or under-vaccinated individuals in communities below the 95% herd-immunity threshold. Imported cases remain limited at 16, while local spread continues across 47 jurisdictions. A CDC advisory committee is reviewing elimination status this month for forwarding to PAHO, with weekly case updates and ongoing surveillance data releases likely to influence trader assessments of year-end totals through December.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$7,829,288Enddatum
31. Dez. 2026Markt eröffnet
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of early August 2026, the CDC has confirmed 2,465 measles cases nationwide, already surpassing the 2,289 recorded for all of 2025 and marking the highest annual total since 1991. Sustained transmission stems primarily from 38 active outbreaks—94% of cases are outbreak-associated—with the majority occurring among unvaccinated or under-vaccinated individuals in communities below the 95% herd-immunity threshold. Imported cases remain limited at 16, while local spread continues across 47 jurisdictions. A CDC advisory committee is reviewing elimination status this month for forwarding to PAHO, with weekly case updates and ongoing surveillance data releases likely to influence trader assessments of year-end totals through December.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen